RASRx is Drug Discovery in United States that focus on developer business. Founded in 2014. They cover business area such as developer, an oral therapy, improved muscle strength, regeneration, decrease muscle inflammation, fibrosis, positive effect, muscle function, an MDX mouse model, disease progression, relief, patient, possibly other muscular dystrophy, physician, complex muscle pathology, Duchenne muscular dystrophy.
2014
( 10 years old in 2024 )
Developer
-
231 Bonetti Drive
Suite 240
San Luis Obispo, CA 93401
United States
Private
developeran oral therapyimproved muscle strengthregenerationdecrease muscle inflammationfibrosispositive effectmuscle functionan MDX mouse modeldisease progressionreliefpatientpossibly other muscular dystrophyphysiciancomplex muscle pathologyDuchenne muscular dystrophy
* We use standard office opening hours in near RASRx's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
RASRx is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), RASRx business is focusing on Developer.
RASRx headquarter office and corporate office address is located in 231 Bonetti Drive Suite 240 San Luis Obispo, CA 93401 United States.
RASRx was founded in United States.
In 2024, RASRx is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with RASRx, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
